Gamble Jones Investment Counsel Has $972,000 Stock Position in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Gamble Jones Investment Counsel reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,771 shares of the pharmacy operator’s stock after selling 1,500 shares during the quarter. Gamble Jones Investment Counsel’s holdings in Walgreens Boots Alliance were worth $972,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Meridian Wealth Management LLC bought a new position in Walgreens Boots Alliance in the first quarter worth approximately $25,000. Weaver Consulting Group acquired a new position in shares of Walgreens Boots Alliance during the first quarter worth $27,000. Sageworth Trust Co acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth $27,000. First Interstate Bank increased its position in shares of Walgreens Boots Alliance by 228.1% during the second quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 422 shares in the last quarter. Finally, TRUE Private Wealth Advisors acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth $38,000. 59.69% of the stock is currently owned by institutional investors.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 15.73% of the stock is owned by corporate insiders.

Shares of NASDAQ WBA traded down $0.68 during mid-day trading on Tuesday, hitting $54.63. The stock had a trading volume of 1,245,105 shares, compared to its average volume of 4,871,895. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76. The company has a 50 day moving average of $52.67 and a two-hundred day moving average of $54.20. Walgreens Boots Alliance Inc has a twelve month low of $49.03 and a twelve month high of $86.31. The firm has a market cap of $49.14 billion, a PE ratio of 9.07, a PEG ratio of 1.36 and a beta of 0.88.

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Tuesday, August 20th were given a $0.458 dividend. This represents a $1.83 annualized dividend and a dividend yield of 3.35%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date was Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio is presently 30.40%.

WBA has been the topic of a number of recent analyst reports. Bank of America reduced their price target on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research report on Monday, June 3rd. Cleveland Research reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 9th. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a research report on Thursday, September 12th. They set a “sell” rating on the stock. Finally, BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 11th. Seven equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $62.29.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Why do companies engage in swaps?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.